Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Guardant Health Inc (NQ: GH )

21.88 -1.19 (-5.16%)
Official Closing Price Updated: 4:15 PM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Guardant Health Inc

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Tesla, Apple, Novavax, Adobe, Guardant Health: Why These 5 Stocks Are Drawing Investors' Attention Today
Major Wall Street indices closed over 2% lower on Thursday after U.S. retail sales saw their steepest drop in close to a year last month, suggesting consumers are reining in spending around the... 
Via Benzinga
Exact Sciences Rockets As Guardant's Blood Test Pales Vs. Cologuard
Exact Sciences' Cologuard has a higher specificity than Guardant's blood test. 
Via Investor's Business Daily
After-Hours Action: What's Going On With Guardant Health, Exact Sciences Shares?
Guardant Health Inc (NASDAQ: GH) and Exact Sciences Corp (NASDAQ: EXAS) shares are moving in different directions in Thursday's after-hours session. Here's a look at what's going on. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Guardant Health announces positive results from pivotal ECLIPSE study evaluating a blood test for the detection of colorectal cancer
From Guardant Health, Inc.
Via Business Wire
8 Analysts Have This to Say About Guardant Health
Via Benzinga
Expert Ratings for Guardant Health
Via Benzinga
Stephens Starts Coverage On This Precision Oncology Company With 66% Upside
Via Benzinga
2 Top Healthcare Stocks to Buy for the Long Haul
These two companies are just getting started. 
Via The Motley Fool
Guardant Health Announces Collaboration With AstraZeneca to Develop Companion Diagnostic to Identify Patients With ESR1-mutated Metastatic Breast Cancer
From Guardant Health, Inc.
Via Business Wire
Guardant Health to Showcase New Data at San Antonio Breast Cancer Symposium 2022 Demonstrating Utility of Its Blood Tests for Advanced-stage Breast Cancer Patients
From Guardant Health, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Analyst Ratings for Guardant Health
Analysts have provided the following ratings for Guardant Health (NASDAQ:GH) within the last quarter: 
Via Benzinga
Cathie Wood Increases Stake In 4 Stocks By Over 1,000% - Plus 4 New Holdings For Ark
Cathie Wood’s ARK Innovation ETF (ARCA: ARKK) is down roughly 63% year-to-date, compared to the NASDAQ which is down at least 29% year-to-date and the S&P 500 down over 16% year-to-date. 
Via Benzinga
Guardant Health Reports Third Quarter 2022 Financial Results
From Guardant Health, Inc.
Via Business Wire
Where Guardant Health Stands With Analysts
Over the past 3 months, 6 analysts have published their opinion on Guardant Health (NASDAQ:GH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Why Guardant Health Stock Fell 5.5% Today
Is Guardant Health as obvious a bargain as this analyst makes it out to be? 
Via The Motley Fool
Guardant Health to Report Third Quarter 2022 Financial Results on November 3, 2022
From Guardant Health, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Upgrades 
Via Benzinga
Why Guardant Health Topped the Market on Thursday
Add another name to the list of the cancer-diagnostic company's bulls. 
Via The Motley Fool
Netflix, Biogen And Other Big Gainers From Wednesday
U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2022
Upgrades 
Via Benzinga
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
Via Benzinga
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
The World Health Organization (WHO) warned that it struggles to identify and 
Via Benzinga
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
Via Benzinga
Biden Administration Pushes 'Cancer Moonshot' Initiative: Report
President Joe Biden channeled John F. Kennedy on the 60th anniversary of the former President's moonshot speech, highlighting the Biden administration's efforts to "end cancer as we know it."  The... 
Via Benzinga
Guardant Health Introduces GuardantINFINITY™ Smart Liquid Biopsy for Research Use to Help Bring New Cancer Therapies to Patients Sooner
From Guardant Health, Inc.
Via Business Wire
Guardant Health to showcase new data at ESMO 2022 demonstrating utility of its portfolio of blood tests for advanced-stage cancer patients
From Guardant Health, Inc.
Via Business Wire
Lululemon, Smartsheet, Okta, And Other Big Gainers From Friday
U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Friday. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.